Hormone and Blood Pressure Relationships in Primary Aldosteronism

References

• Cain J. P., Tuck M. L., Williams G. H., Dluhy R. G., Rosenoff S. H. The regulation of aldosterone secretion in primary aldosteronism. Am J Med 1972; 53: 627–637
   PubMed Web of Science ®Google Scholar
• Kem D. C., Weinberger M. H., Gomez-Sanchez C., Kramer N. J., Lerman R., Furuyama S., Nugent C. A. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism. J Clin Invest 1973; 52: 2272–2277
   PubMed Web of Science ®Google Scholar
• Vetter H., Berger M., Armbruster H., Siegenthaler W., Werning C., Vetter W. Episodic secretion of aldosterone in primary aldosteronism: Relationship to cortisol. Clin Endocr 1974; 3: 41–48
   PubMed Web of Science ®Google Scholar
• Schambelan M., Brust N. L., Chang B. CF, Slater K. L., Biglieri E. G. Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism. J Clin Endocrinol Metab 1976; 43: 115–131
   PubMed Web of Science ®Google Scholar
• Espiner E. A., Donald R. A. Aldosterone regulation in primary aldosteronism: Influence of salt balance, posture and ACTH. Clin Endocr 1980; 12: 277–286
   PubMed Web of Science ®Google Scholar
• Wenting G. J., Man In'T, Veld A. J., Verhoeven R. P., Derkx F. HM, Schalekamp MA D.H. Volume-pressure relationships during development of mineralocorticoid hypertension in man. Circ Res 1977; 40: I163–I170
   PubMed Web of Science ®Google Scholar
• Wenting G. J., Man In'T, Veld A. J., Schalekamp M. ADH. Time-course of vascular resistance changes in mineralocorticoid hypertension in man. Clin Sci 1981; 61: 97s–100s
   PubMed Web of Science ®Google Scholar
• Davies D. L., McElroy K., Atkinson A. B., Brown J. J., Cumming A. MM, Fraser R., Leckie B. J., Lever A. F., Mackay A., Morton J. J., Robertson J. I.S. Relationship between exchangeable sodium and blood pressure in different forms of hypertension in man. Clin Sci 1979; 57: 69a–75s
   PubMed Web of Science ®Google Scholar
• Tarazi R. C., Ibrahim M. M., Bravo E. L., Dustan H. P. Hemodynamic characteristics of primary aldosteronism. New Engl J Med 1973; 289: 1330–1335
   PubMed Web of Science ®Google Scholar
• Millar-Craig M. W., Hawes D., Whittington J. R. New system for recording ambulatory blood pressure in man. Med & Biol Eng & Comp 1978; 16: 727–731
   PubMed Web of Science ®Google Scholar
• Espiner E. A., Christlieb A. R., Amsterdam E. A., Jagger P. I., Dobrzinsky S. J., Lauler D. P., Hickler R. B. The pattern of plasma renin activity and aldosterone secretion in normal and hypertensive subjects before and after saline infusions. The pattern of electrolyte excretion in normal and hypertensive subjects before and after saline infusions. Amer J Cardiol 1971; 27: 585–594
   Google Scholar
• McAreavey D., Cumming A. MM, Sood V. P., Leckie B. J., Morton J. J., Murray G. D., Robertson J. I.S. The effect of oral prazosin on blood pressure and plasma concentrations of renin and angiotensin II in man. Clin Sci 1981; 61: 457s–460s
   PubMed Web of Science ®Google Scholar
• Millar-Craig M. W., Bishop C. N., Raftery E. B. Circadian variations of blood pressure. Lancet 1978; i: 795–797
   Google Scholar
• Mann S., Millar-Craig M. W., Balasubramanian V., Cashman P. MM, Raftery E. B. Ambulant blood pressure: reproducibility and the assessment of interventions. Clin Sci 1980; 59: 497–501
   PubMed Web of Science ®Google Scholar
• Dunn P. J., Espiner E. A. Outpatient screening tests for primary aldosteronism. Aust NZ J Med 1976; 6: 131–135
   PubMedGoogle Scholar
• Lun S., Espiner E. A., Nicholls M. G., Yandle T. G. A direct radioimmunoassay for aldosterone in plasma. Clin Chem 1983; 29: 268–271
   PubMed Web of Science ®Google Scholar
• Peuler J. D., Johnson G. A. Simultaneous single isotope radioenzymatic assays of plasma norepinephrine, epinephrine and dopamine. Life Sci 1977; 21: 625–633
   PubMed Web of Science ®Google Scholar
• Statistical Methods in Medical Research, P. Armitage. Blackwell Scientific Publications, Oxford 1971; pp281
   Google Scholar
• Kornel L., Ramsay C., Kanamarlapudi N., Travers T., Packer W. Evidence for the presence in arterial walls of intra-cellular-molecular mechanisms for action of mineralo-corticoids. Clin & Exper Hyper 9 & 1982; 10: 1561–1582
   Google Scholar
• Purdy R. E., Weber M. A., Drayer J. I.M. Vasoconstrictor effects of aldosterone in isolated vascular tissue. Clin & Exper Hyper 9 G 1982; 10: 1583–1591
   Google Scholar
• Moura A. M., Worcel M. Arterial smooth muscle effects of aldosterone: action on ionic fluxes. Clin Sci 1982; 63: 35s–36s
   Web of Science ®Google Scholar
• Burstyn P. G., Horrobin D. F. Possible mechanism of action for aldosterone-induced hypertension. Lancet 1970; i: 973–976
   Google Scholar
• Tanz R. D. Studies on the inotropic action of aldosterone on isolated cardiac tissue preparations; including the effects of pH, Ouabain and SC-9109. J Pharmacol Exp Therapeut 1962; 135: 71–78
   PubMed Web of Science ®Google Scholar
• Kem D. C., Weinberger M. H., Higgins J. R., Kramer N. J., Gomez-Sanchez C., Holland O. B. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension. J Clin Endocr & Metab 1978; 46: 552–560
   PubMed Web of Science ®Google Scholar
• Wenting G. J., Man In'T Veld A. J., Derkx F. H., Brummelen P. V., Schalekamp M. ADH. ACTH-dependent aldosterone excess due to adrenocortical adenoma: A variant of primary aldosteronism. J Clin Endocr Metab 1978; 46: 326–335
   PubMed Web of Science ®Google Scholar
• Hoefnagels W. HL, Drayer J. IM, Smals A. GH, Benraad T. J., Kloppenborg P. W.C. Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism. J Clin Endocrinol & Metab 1980; 51: 1330–1336
   PubMed Web of Science ®Google Scholar
• Guthrie G. P. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism. J Lab Clin Med 1981; 98: 364–373
   PubMedGoogle Scholar
• Zager P. G., Luetscher J. A. Effects of angiotensin II and ACTH on aldosterone secretion. Clin Exper Hyper 9 & 1982; 10: 1481–1490
   Google Scholar
• Newton M. A., Laragh J. H. Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects in essential hypertension and in primary aldosteronism. J Clin Endocrinol 1968; 28: 1006–1022
   PubMed Web of Science ®Google Scholar
• Tuck M. L., Sowers J. R., Asp N. D., Viosca S. P., Berg G., Mayes D. M. Mineralocorticoid response to low dose adreno-corticotropin infusion. J Clin Endocrinol & Metab 1981; 52: 440–445
   PubMed Web of Science ®Google Scholar
• Venning E. H., Dyrenfurth I., Dossetor J. B., Beck J. C. Influence of alterations in sodium intake on urinary aldosterone response to corticotropin in normal individuals and patients with essential hypertension. Metabolism 1962; 11: 254–260
   PubMed Web of Science ®Google Scholar
• Williams G. H., Dluhy R. G., Underwood R. H. The relationship of dietary potassium intake to the aldosterone simulating properties of ACTH. Clin Sci 1970; 39: 489–496
   PubMed Web of Science ®Google Scholar
• Gordon R. D., Kuchel O., Liddle G. W., Island D. P. Role of the sympathetic nervous system in regulating renin and aldosterone production in man. J Clin Invest 1967; 46: 599–605
   PubMed Web of Science ®Google Scholar
• Davies R., Slater J. D.H. Is the adrenergic control of renin release dominant in man. Lancet 1976; ii: 594–596
   Google Scholar
• Morganti A. L., Lopez-Ovejero J. A., Pickering T. G., Laragh J. H. Role of the sympathetic nervous system in mediating the renin response to head-up tilt. Their possible synergism in defending blood pressure against postural changes during sodium deprivation. Amer J Cardiol 1979; 43: 600–607
   Google Scholar